Extracavitary KSHV-associated Large B-Cell Lymphoma

Zenggang Pan(University of Colorado Anschutz Medical Campus), Yongsheng Ren(University of Alabama at Birmingham), Lanting Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Vishnu Reddy(University of Colorado Cancer Center), Igor B. Rozenvald(Tufts Medical Center), David G. Wilson(Worcestershire Royal Hospital), Huan‐You Wang(University of California San Diego), Qianyun Zhang(University of New Mexico), Zheng-Bin Lu, Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Tobi Quinto(Tufts Medical Center)

The American Journal of Surgical Pathology

July 13, 2012

10.1097/pas.0b013e31825b38ec

Cited by 110

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.

|Journal of Biological Chemistry|1993|375

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus.

|Proceedings of the National Academy of Sciences|1992|260